Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United States is a research paper published in JCO Oncology Practice (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: T32 CA009515
National Institutes of Health
Grant: 5T32CA009515-05
TRAINING IN CANCER BIOLOGY AND MARROW TRANSPLANTATION
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals